Gene · 554
NIH grants1,257
NIH grants whose papers are about the gene, through NIH's grant-paper links.
301 to 320 of 1,257
Download this page as JSON| Grant | Title | AVPR2 papers | Newest fiscal year |
|---|---|---|---|
| T32HL069749 | Postdoctoral Training in Cardiovascular Clinical Research | 1 | 2023 |
| U01CA271318 | Multi-modal data integration to identify kinase substrates | 1 | 2023 |
| U24CA237683 | University of Michigan Quantitative Co-Clinical Imaging Research Resource | 1 | 2023 |
| UH3DK122638 | Engineering a Human Microphysiological System for the Characterization of Islet-Immune Interactions | 1 | 2023 |
| P30DK079307 | Pittsburgh Center for Kidney Research | 4 | 2022 |
| P30DK079310 | George M. O'Brien Kidney Center at Yale | 3 | 2022 |
| R01GM066099 | Functional Determinants in G-Protein-Coupled Receptors | 3 | 2022 |
| R01GM097480 | Etiology of Microvascular Changes in Gram-positive Sepsis: Mechanisms and Therapeutic Options | 3 | 2022 |
| F30HL149213 | Structural Determination of Novel GPCR Signaling Complexes that Mediate Sustained G Protein Signaling | 2 | 2022 |
| K23DK116720 | Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes Study | 2 | 2022 |
| KL2TR002545 | CTSA Institutional Mentored Career Development Program (KL2) | 2 | 2022 |
| P50MH100023 | Silvio O. Conte Center for Oxytocin and Social Cognition | 2 | 2022 |
| R01CA221289 | GPCR - Linked RhoGEFs in Tumor Growth and Metastasis | 2 | 2022 |
| R01DK096015 | Novel roles of integrin b1 signaling in regulating principal cell function andmaintaining collecting duct integrity | 2 | 2022 |
| R01GM127359 | Discovering the mechanism of GPCR-mediated arrestin stimulation to enable effective drug therapies | 2 | 2022 |
| R21CA243052 | Regulation of Melanoma Cell Malignancy by Compartmentalized Chemokine Receptor Signaling | 2 | 2022 |
| T32GM008061 | Cellular and Molecular Basis of Disease Training Program | 2 | 2022 |
| ZIAMH002498 | Roles of Oxytocin and Vasopressin in Brain | 2 | 2022 |
| F31AG067629 | Effects of apolipoprotein E isoform and amifostine on memory-related DNA double strand breaks and immediate-early gene expression | 1 | 2022 |
| F31DK126397 | Engineered tolerogenic exosomes for treating type 1 diabetes autoimmunity | 1 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/554/grants?page=16